Chief Financial Officer of Nurix Therapeutics, Inc. (NASDAQ:NRIX), Van Houte Hans, sells 13,583 shares worth $481,621

According to Nurix Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 22 04:09 PM, company Chief Financial Officer, Van Houte Hans disclosed selling 13,583 shares at a cost of $35.46. At the time of this transaction (Feb 18), this trade was worth $481,621 in total. As of Feb 18, Van Houte Hans now owns 0 shares in total worth about $0.0.

For the last few recent trades made by Nurix Therapeutics, Inc. (NASDAQ:NRIX) Chief Financial Officer, Van Houte Hans, we have the following information:

Posted by George Daniels on Monday February 22 2021, 6:53 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0